Autologous NK cell therapy (Takara Bio)

N/A

Report date: 2022/09/06 18:12:15

Base Information

Drug NameAutologous NK cell therapy (Takara Bio)

Drug Alias NameNK cell therapy - Takara Bio

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy

Mechanisms of ActionImmunostimulantsCell replacements

TargetsNot applicable

Therapy Area/IndicationsGastrointestinal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesTakara Bio Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesTakara Bio Inc

Active IndicationsN/A

Inactive IndicationsGastrointestinal Neoplasms

ATC CodeN/A